Back to results
US 2019/0169303 A1Published application
Humanized Anti-OX40 Antibodies and Uses Thereof
OwnerScott A. Hammond, Michael Oberst +2inventors
InventorsScott A. Hammond, Michael Oberst, Qun Du, Melissa Damschroder
Life of this patent
Estimating the term…
Abstract
The disclosure provides humanized anti-OX40 antibodies. Also provided are methods of making such antibodies, and methods of use, e.g., treatment of cancer.
Claims39
1-70. (cancelled)
An antibody or antigen-binding fragment thereof, comprising:
- a humanized heavy chain variable region (VH) and a humanized light chain variable region (VL);
- wherein the VH comprises an amino acid sequence with the formula:
- HFW1-HCDR1-HFW2-HCDR2-HFW3-HCDR3-HFW4,
- wherein HFW 1 is SEQ ID NO:
- 6 or SEQ ID NO:
- 7, HCDR1 is SEQ ID NO:
- 8, HFW2 is SEQ ID NO:
- 9, SEQ ID NO:
- 10, SEQ ID NO:
- 11, SEQ ID NO:
- 12, or SEQ ID NO:
- 13, HCDR2 is SEQ ID NO:
- 14, SEQ ID NO:
- 15 or SEQ ID NO:
- 16, HFW3 is SEQ ID NO:
- 17, SEQ ID NO:
- 18, SEQ ID NO:
- 19, SEQ ID NO:
- 20, SEQ ID NO:
- 21, SEQ ID NO:
- 22, SEQ ID NO:
- 23, or SEQ ID NO:
- 24, HCDR3 is SEQ ID NO:
- 25, SEQ ID NO:
- 26, or SEQ ID NO:
- 27, and HFW4 is SEQ ID NO:
- 28;
- wherein the VL comprises the amino acid sequence SEQ ID NO:
- 29 or SEQ ID NO:
- 32;
- and
- wherein the antibody or antigen-binding fragment thereof can specifically bind to human OX40.
29 more elements
Dependencies are inferred from the claim text.